As a doctor, I am thankful for the public support during this pandemic. But I also know how hero stories usually go. The public puts heroes on a pedestal and eventually turns against them.
Tezepelumab is associated with reduced exacerbations, hospitalizations and ER visits in people with severe, uncontrolled asthma. It may also challenge the current step of biomarker assessment before initiating treatment with a biologic.
